Coagulation system and platelets are fully activated in uncomplicated sepsis

Critical Care Medicine

Volumn 28, Issue 2, 2000, Pages 451-457

  Mavrommatis, Antonis C ^a   Theodoridis, Thodoris ^b   Orfanidou, Androula ^b   Roussos, Charis ^a   Christopoulou Kokkinou, Vana ^b   Zakynthinos, Spyros ^a,b  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^b EVANGELISMOS HOSPITAL   (Greece)

Author keywords

Coagulation; Coagulation factors; Common pathway; Extrinsic pathway; Intrinsic pathway; Molecular activation markers of coagulation; Multiple organ dysfunction syndrome; Multiple organ failure; Platelets; Sepsis; Septic shock

Indexed keywords

BLOOD CLOTTING FACTOR 12;

ADOLESCENT; ADULT; AGED; ARTICLE; BLOOD CLOTTING; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE SEVERITY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PARTIAL THROMBOPLASTIN TIME; PRIORITY JOURNAL; PROTHROMBIN TIME; SEPSIS; THROMBOCYTE COUNT;

EID: 0034087599     PISSN: 00903493     EISSN: None     Source Type: Journal    
DOI: 10.1097/00003246-200002000-00027     Document Type: Article

References (43)

1. 1. Parrillo JE, Parker MM, Natanson C, et al: Septic shock: Advances in the understanding of pathogenesis, cardiovascular dysfunction, and therapy. Ann Intern Med 1990; 113: 227-242
2. 2. Increase in national hospital discharge survey rates for septicemia: United States, 1979-1987. MMWR Morb Mortal Wkly Rep 1990; 39:31-34
3. 3. Levi M, ten Cate H, van der Poll T, et al: Pathogenesis of disseminated intravascular coagulation in sepsis. JAMA 1993; 270: 975-979
4. 4. Corrigan JJ, Ray WL, May N: Changes in the blood coagulation system associated with septicemia. N Engl J Med 1968; 279:851-856
5. 5. Mason JW, Kleesberg U, Dolan P, et al: Plasma kallikrein and Hageman factor in gram-negative bacteremia. Ann Intern Med 1970; 75:545-551
6. 6. Hesselvik JF, Blomback M, Brodin B, et al: Coagulation, fibrinolysis, and kallikrein systems in sepsis: Relation to outcome. Crit Care Med 1989; 17:724-733
7. 7. Fourrier F, Lestavel P, Chopin C, et al: Meningococcemia and purpura fulminans in adults: Acute deficiencies of proteins C and S and early treatment with antithrombin III concentrates. Intensive Care Med 1990; 16: 121-124
8. 8. Hack CE, Nuijens JH, Strack van Schijndel RJM, et al: A model for the interplay of inflammatory mediators in sepsis: A study in 48 patients. Intensive Care Med 1990; 16(Suppl 3):S187-S191
9. 9. Fourrier F, Chopin C, Goudemand J, et al: Septic shock, multiple organ failure, and disseminated intravascular coagulation: Compared patterns of antithrombin III, protein C, and protein S deficiencies. Chest 1992; 101: 816-823
10. 10. Mc Manus ML, Churchwell KB: Coagulopathy as a predictor of outcome in meningococcal sepsis and the systemic inflammatory response syndrome with purpura. Crit Care Med 1993; 21:706 -711
11. 11. Leithauser B, Matthias FR, Nicolai U, et al: Hemostatic abnormalities and the severity of illness in patients at the onset of clinically defined sepsis: Possible indication of the degree of endothelial cell activation? Intensive Care Med 1996; 22:631-636
12. 12. The ACCP/SCCM consensus conference committee: Definitions for sepsis and guidelines for the use of innovative therapies in sepsis. Chest 1992; 101:1644-1655
13. 13. Suffredini AF, Harpel PC, Parrillo JE: Promotion and subsequent inhibition of plasminogen activation after administration of intravenous endotoxin to normal subjects. N Engl J Med 1989; 320:1165-1172
14. 14. Van Deventer SJH, Buller HR, ten Cate JW, et al: Experimental endotoxemia in human: Analysis of cytokine release and coagulation, fibrinolysis, and complement pathways. Blood 1990; 76:2520-2526
15. 15. Van der Poll T, Buller HR, ten Cate H, et al: Activation of coagulation after administration of tumor necrosis factor to normal subjects. N Engl J Med 1990; 322:1622-1627
16. 16. Rao AK, Schapira M, Clements ML, et al: A prospective study of platelets and plasma proteolytic systems during the early stages of Rocky Mountain spotted fever. N Engl J Med 1988; 318:1021-1028
17. 17. Knaus WA, Draper EA, Wanger D, et al: APACHE II: A severity of disease classification system. Crit Care Med 1985; 13: 818-829
18. 18. Knaus WA, Wagner DP: Multiple systems organ failure: Epidemiology and prognosis. Crit Care Med 1989; 5:221-232
19. 19. Deitch EA: Multiple organ failure: Pathophysiology and potential future therapy. Ann Surg 1992; 216:117-134
20. 20. Holmes S: A simple sequentially rejective multiple test procedure. Scand J Stat 1979; 6:65-70
21. 21. Kaplan KL, Own J: Plasma levels of β-thromboglobulin and platelet factor 4 as indices of platelet activation in vivo. Blood 1981; 57: 199-202
22. 22. De Boer JP, Creasy AA, Chang A, et al: Activation patterns of coagulation and fibrinolysis in baboons following infusion with lethal and sublethal dose of E. coli. Circ Shock 1993; 39:59-67
23. 2 in sepsis: Studies in non-human primates after interleukin-1 administration and during lethal bacteremia. Blood 1995; 86:1027-1034
24. 24. van der Poll T, Levi M, Hack CE, et al: Elimination of interleukin-1 attenuates coagulation activation in experimental endotoxemia in chimpanzees. J Exp Med 1994; 179: 1253-1259
25. 25. Elbert T, Ray WJ, Kowalik ZJ, et al: Chaos and physiology: Deterministic chaos in excitable cell assemblies. Physiol Rev 1994; 74: 1-47
26. 26. Teitel JM, Bauer KA, Lau HK, et al: Studies of the prothrombin activation pathway utilizing radioimmunoassays for the F2/F1 + 2 fragment and thrombin-antithrombin complex. Blood 1982; 59:1086-1097
27. 27. Nossel HL, Ti M, Kaplan KL, et al: The generation of fibrinopeptide A in clinical blood samples: Evidence for thrombin activity. J Clin Invest 1976; 58:1136-1144
28. 28. Slaughter TF, LeBleu TH, Douglas JM, et al: Characterization of prothrombin activation during cardiac surgery by hemostatic molecular markers. Anesthesiology 1994; 80: 520-526
29. 29. Furie B, Furie BC: Molecular basis of blood coagulation. In: Hematology: Basic Principles and Practice. Second Edition. Hoffman R, Benz EJ, Shattil SJ, et al (Eds). New York, Churchill Livingstone, 1995, pp 1566-1587
30. 30. Niemetz J: Coagulant activity of leukocytes: Tissue factor activity. J Clin Invest 1972; 51: 307-313
31. 31. Colucci M, Balconi G, Lounzet R, et al: Cultured human endothelial cells generate tissue factor in response to endotoxin. J Clin Invest 1983; 71:1893-1899
32. 32. Kalter EJ, Daha MR, ten Cate JW, et al: Activation and inhibition of Hageman factor-dependent pathways and the complement system in uncomplicated bacteremia or bacterial shock. J Infect Dis 1985; 151: 1019-1027
33. 33. Matsumoto K, Yamamoto T, Kamata R, et al: Pathogenesis of serratial infection: Activation of the Hageman factor-prekallikrein cascade by serratial protease. J Biochem 1984; 96:739-749
34. 34. Carvalho AC, De Marinis S, Scott CF, et al: Activation of contact system of plasma proteolysis in the adult respiratory distress syndrome. J Lab Clin Med 1988; 112:170-177
35. 35. Wagner DD, Ginsburg D: Structure, biology, and genetics of von Willebrand factor. In: Hematology: Basic Principles and Practice. Second Edition. Hoffman R, Benz EJ, Shattil SJ, et al (Eds). New York, Churchill Livingstone, 1995, pp 1717-1725
36. 36. Van der Lelie J, von dem Boren AK: Increased mean platelet volume in septicemia. J Clin Pathol 1983; 36:693-699
37. 37. Kaufman RJ, Antonarakis SE: Structure, biology, and genetics of factor VIII. In: Hematology: Basic Principles and Practice. Second Edition. Hoffman R, Benz EJ, Shattil SJ, et al (Eds). New York, Churchill Livingstone, 1995, pp 1633-1648
38. 38. Teitel JM, Rosenberd RD: Protection of factor Xa from neutralization by the heparin-antithrombin complex. J Clin Invest 1983; 71:1383-1391
39. 39. Lindhout T, Franssen J, Willems G: Kinetics of the inhibition of tissue factor-factor VIIa by tissue factor pathway inhibitor. Thromb Haemost 1995; 74:910-915
40. 40. Brass LF: Molecular basis of platelet activation. In: Hematology: Basic Principles and Practice. Second Edition. Huffman R, Benz EJ, Shattil SJ, et al (Eds). New York, Churchill Livingstone, 1995, pp 1536-1552
41. 41. Al-Sarraf AA, Owunwanne A, Christenson JT: The role of low molecular weight dextran on platelet pulmonary trapping during endotoxin-induced shock. Resuscitation 1989; 17: 1-9
42. 42. Kalter ES, Dijk WC, Timmerman A, et al: Activation of purified human plasma prekallikrein triggered by cell wall fractions of E. coli and Staphylococcus aureus. J Infect Dis 1983; 4:682-691
43. 43. Molla A, Yamamoto T, Akaike T, et al: Activation of Hageman factor and prekallikrein and generation of kinin by various microbial proteases. J Biol Chem 1989; 264: 10589-10594